Science news and articles on health, environment, global warming, stem cells, bird flu, autism, nanotechnology, dinosaurs, evolution -- the latest discoveries in astronomy, anthropology, biology, chemistry, climate & bioengineering, computers, engineering ; medicine, math, physics, psychology, technology, and more from the world's leading research centers universities.

PacBio’s SMRT sequencing provides scientists with a superior gorilla genome reference

0

MENLO PARK, Calif., March 31, 2016 — Pacific Biosciences of California, Inc., (Nasdaq:PACB) the pioneer and leader in long-read sequencing using its Single Molecule, Real-Time (SMRT®) technology, today announced that scientists from the University of Washington, the McDonnell Genome Institute at Washington University in St. Louis, and other institutions have published the best genome assembly of the gorilla to date — more than 150-fold improvement over previous assemblies — using long-read SMRT Sequencing from Pacific Biosciences. The peer-reviewed paper appears in the April 1 issue of the journal Science and is available online today.

Analysis of the gorilla genome promises to shed light on biological mechanisms behind speech, disease, neurological behavior, and other traits that separate us from our closest primate relatives. The previous gorilla genome assembly, built with short-read and Sanger sequencing data, was highly fragmented, containing more than 400,000 gaps with missing sequence, and was constructed using the human genome as a guiding reference. The new assembly, which was carried out de novo (i.e., without any reference information), represents a remarkable decrease in assembly fragmentation (433,861 pieces previously vs. 15,997 with PacBio data, or a >96% reduction in the degree of fragmentation). The PacBio assembly recovers 93% of the gaps and nearly all exons missing from the previous assembly, and provides at least 148 Mbp of additional euchromatic sequence. The authors used information from six additional western lowland gorilla genomes to create a pan-reference genome for use by the scientific community.

"Our results demonstrate the utility of long-read sequence technology to generate high-quality working draft genomes of complex vertebrate genomes without guidance from preexisting reference genomes," the authors report in the paper. "The genome assembly that results from using the long-read data provides a more complete picture of gene content, structural variation and repeat biology, as well as allows us to refine population genetic and evolutionary inferences."

The team used PacBio's SMRT Sequencing, followed by assembly and polishing with PacBio's new FALCON assembly and Quiver consensus algorithms to create a more complete picture of the gorilla genome. FALCON enabled the researchers to traverse most repetitive structures, validating the utility of the experimental tool for assembling complex genomes and representing the first published use of this genome assembler. More information about the assembly is provided in the PacBio blog.

Jonas Korlach, Chief Scientific Officer of Pacific Biosciences, commented: "We are delighted by the authors' suggestion that our approach provides a routine way to assemble complex genomes without relying on reference genomes, bringing high-quality de novo mammalian assemblies within the reach of individual labs. This paper also demonstrates the importance of true long reads over scaffolding approaches for generating highly contiguous genomes without gaps, which is necessary for understanding gene content, population genetic diversity, ancestral evolution, and species biology." ave just published the best genome assembly of the gorilla to date,using long-read SMRT Sequencing from Pacific Biosciences. The peer-reviewed paper appears in the April 1 issue of the journal Science and is available online today.

###

The paper, "Long-read sequence assembly of the gorilla genome," by Gordon et al. is available at: http://science.sciencemag.org/cgi/doi/10.1126/science.aae0344

About Pacific Biosciences

Pacific Biosciences of California, Inc. (NASDAQ:PACB) offers sequencing systems to help scientists resolve genetically complex problems. Based on its novel Single Molecule, Real-Time (SMRT®) technology, Pacific Biosciences' products enable: de novo genome assembly to finish genomes in order to more fully identify, annotate and decipher genomic structures; full-length transcript analysis to improve annotations in reference genomes, characterize alternatively spliced isoforms in important gene families, and find novel genes; targeted sequencing to more comprehensively characterize genetic variations; and real-time kinetic information for epigenome characterization. Pacific Biosciences' technology provides high accuracy, ultra-long reads, uniform coverage, and is the only DNA sequencing technology that provides the ability to simultaneously detect epigenetic changes. PacBio® sequencing systems, including consumables and software, provide a simple, fast, end-to-end workflow for SMRT Sequencing. More information is available at http://www.pacb.com.

Forward-Looking Statements

All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to future uses, quality or performance of, or benefits of using, products or technologies, and other future events. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, changes in circumstances and other factors that are, in some cases, beyond Pacific Biosciences' control and could cause actual results to differ materially from the information expressed or implied by forward-looking statements made in this press release. Factors that could materially affect actual results can be found in Pacific Biosciences' most recent filings with the Securities and Exchange Commission, including Pacific Biosciences' most recent reports on Forms 8-K, 10-K and 10-Q, and include those listed under the caption "Risk Factors."

Pacific Biosciences undertakes no obligation to revise or update information in this press release to reflect events or circumstances in the future, even if new information becomes available.

Contacts

Media:
Nicole Litchfield
415.793.6468
[email protected]

Investors:
Trevin Rard
650.521.8450
[email protected]

Media Contact

Nicole Litchfield
[email protected]
415-793-6468

http://www.bioscribe.com

Leave A Reply

Your email address will not be published.